Measuring Response to Treatment in Multiple Myeloma

C. Ola Landgren

C. Ola Landgren discusses ways to measure response to treatment in multiple myeloma.

C. Ola Landgren, hematologic oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center, discusses ways to measure response to treatment in multiple myeloma. Landgren addressed this topic in a talk last week at the 33rd Annual Chemotherapy Foundation Symposium, a meeting of over 1,000 physicians and other oncology professionals in New York City.

Related Content:

CURE TVMyeloma
Novel Injectable Drug Shows Promise in Relapsed/Refractory Myeloma
Single-Injection CAR-T Cell Therapy Improves Long-Term Treatment Responses in Relapsed/Refractory Multiple Myeloma
Kyprolis-Based Regimen Induces Similar Results as Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma